Cresco Labs Inc.
CRLBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $316 | $440 | $537 | $1,750 |
| - Cash | $138 | $103 | $119 | $224 |
| + Debt | $640 | $683 | $670 | $625 |
| Enterprise Value | $818 | $1,020 | $1,088 | $2,151 |
| Revenue | $724 | $771 | $843 | $822 |
| % Growth | -6% | -8.5% | 2.6% | – |
| Gross Profit | $364 | $330 | $407 | $406 |
| % Margin | 50.3% | 42.8% | 48.3% | 49.5% |
| EBITDA | $109 | -$15 | -$10 | -$157 |
| % Margin | 15% | -1.9% | -1.2% | -19.1% |
| Net Income | -$74 | -$176 | -$212 | -$320 |
| % Margin | -10.3% | -22.8% | -25.2% | -38.9% |
| EPS Diluted | -0.22 | -0.54 | -0.71 | -1.22 |
| % Growth | 59.3% | 23.9% | 41.8% | – |
| Operating Cash Flow | $132 | $59 | $19 | $14 |
| Capital Expenditures | -$23 | -$58 | -$86 | -$97 |
| Free Cash Flow | $109 | $1 | -$67 | -$83 |